Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181896 · ClinicalTrials.gov registry record · Phase 4
Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT00181896: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00181896 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181896, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is an 8-week open label study of bupropion SR in the treatment of youth with bipolar depression with adequate mood stabilization. All youth will be closely monitored for treatment emergent manic activation and drug-drug interactions with ongoing antimanic agents. The main objective of this study is to assess the safety and effectiveness of bupropion SR in the treatment of bipolar depression in children and adolescents.
Interventions
- DRUG bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181896
The ClinicalTrials.gov registry entry for NCT00181896 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bupropion SR is the first listed.
NCT00181896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181896 about?
NCT00181896 is a clinical study titled "Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder". This is an 8-week open label study of bupropion SR in the treatment of youth with bipolar depression with adequate mood stabilization. All youth will be closely monitored for treatment emergent manic activation and drug-drug interactions with ongoing antimanic agents. The main objective of this stu...
What is the current status of trial NCT00181896?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2005-01.
What interventions are being tested in trial NCT00181896?
The interventions under investigation include: bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00181896?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.